Main functions of liver includes removing harmful substances from blood, storing nutrients and vitamins, maintaining proper balance of chemical levels in the body and many more. Diseases which cause improper functioning of liver are termed as Liver diseases. There are about hundreds of different known forms of liver diseases that ultimately lead to a condition named cirrhosis of liver which causes permanent damage of liver cells.
The prevalence of liver diseases is most common in developing countries.
The primary reasons behind the growth of such diseases are excessive alcohol consumption, obesity, viral hepatitis, genetic disorder and these are the growth drivers for the liver disease treatment market.
Drugs used to treat liver diseases includes Antivirals, immune globulins targeted therapy, Corticosteroids, immunosuppressive agents, antimetabolites, anabolic steroids, alcohol-abuse drugs, anti-rejection drugs, infection-fighting drug, Antifungal prophylaxis, and gallstone-solubilizing agents.
In recent years, sales of drugs used to treat liver diseases has witnessed moderate growth rate. Moreover in 2011, the market grew at a moderate rate after stagnating in 2010. U.S. commands the largest share of the overall global liver disease treatment market closely followed by Europe. The treatment for hepatitis is the major segment of liver disease treatment market and has potential to grow at a faster pace due to the increased incidence of hepatitis C in developing countries.
The major players in the liver diseases treatment market include Abbott Laboratories, Bayer Schering Ag, Bristol-Myers Squibb, Eli Lilly, Merck & Co., Novartis, Pfizer, Roche, Sanofi-Aventis, Takeda Pharmaceutical, and Zydus Pharmaceuticals Inc.
The report analyses the global scenario of Liver Disease Treatment Market discussing detailed overview and market figures. The research report analyses the industry growth rate, industry capacity, and industry structure. The report analyses the historical data and forecasts the Liver Disease Treatment Market size, production forecasts along with key factors driving and restraining the market.